Literature DB >> 17457610

Anatomic wide hepatectomy for treatment of hepatocellular carcinoma.

Toshiya Ochiai1, Teruhisa Sonoyama, Shojiro Kikuchi, Tokunari Okayama, Hiroo Konishi, Masahiro Kitagawa, Tomoyuki Tagi, Yuji Ueda, Eigo Otsuji.   

Abstract

PURPOSE: We aimed to clarify the prognostic impact of the anatomic extent of hepatic resection (Hr) related to the tumor hepatic involvement (H) on patients' survival in the treatment of hepatocellular carcinoma (HCC).
METHOD: The 305 patients with HCC who had undergone hepatectomy were analyzed retrospectively. The patients were classified into the anatomic wide hepatectomy (Hr > H hepatectomy, i.e. Hr was larger than H, n = 93) group and the other hepatectomies (Hr < or = H hepatectomy, i.e. Hr was equal to or smaller than H, n = 212) group. We compared the clinico-pathologic features between the two hepatectomy groups and the prognostic factors associated with postoperative HCC recurrence by using the Cox's proportional hazard model.
RESULTS: After median follow-up duration of 50 months (range 1-223 months), in Hr > H and Hr < or = H hepatectomy groups, the cumulative 3, 5, 10 year disease-free survival rates were 58.1, 44.6, 27.1% and 49.2, 33.0, 14.6%, respectively (P = 0.043). The overall survival was not significantly different between the groups (P = 0.401). Multivariate analysis revealed that Hr > H hepatectomy was an independent favorable factor for disease-free survival: the relative risk was 0.64 (95% confidence interval, 0.43-0.95; P = 0.026).
CONCLUSION: Anatomic wide (Hr > H) hepatectomy is a favorable procedure of choice in HCC for possibly reducing the risk of postoperative recurrence.

Entities:  

Mesh:

Year:  2007        PMID: 17457610     DOI: 10.1007/s00432-007-0205-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.322


  22 in total

1.  Indications and results of resection for hepatocellular carcinoma.

Authors:  V Ziparo; G Balducci; G Lucandri; P Mercantini; G Di Giacomo; E Fernandes
Journal:  Eur J Surg Oncol       Date:  2002-11       Impact factor: 4.424

2.  Prognostic impact of anatomic resection for hepatocellular carcinoma.

Authors:  Kiyoshi Hasegawa; Norihiro Kokudo; Hiroshi Imamura; Yutaka Matsuyama; Taku Aoki; Masami Minagawa; Keiji Sano; Yasuhiko Sugawara; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

3.  Resection of hepatocellular carcinoma in patients with cirrhosis.

Authors:  J Balsells; R Charco; J L Lazaro; E Murio; V Vargas; E Allende; C Margarit
Journal:  Br J Surg       Date:  1996-06       Impact factor: 6.939

4.  Postoperative recurrence of hepatocellular carcinoma.

Authors:  T Nagao; S Inoue; F Yoshimi; M Sodeyama; Y Omori; T Mizuta; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

5.  Recurrence of hepatocellular carcinoma after surgery.

Authors:  J Yamamoto; T Kosuge; T Takayama; K Shimada; S Yamasaki; H Ozaki; N Yamaguchi; M Makuuchi
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

6.  Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.

Authors:  S Takano; O Yokosuka; F Imazeki; M Tagawa; M Omata
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

7.  An initial experience and evolution of laparoscopic hepatic resectional surgery.

Authors:  Joseph F Buell; Mark J Thomas; Travis C Doty; Keith S Gersin; Todd D Merchen; Manish Gupta; Steven M Rudich; E Steve Woodle
Journal:  Surgery       Date:  2004-10       Impact factor: 3.982

8.  Hand-assisted laparoscopic hepatectomy after partial splenic embolization.

Authors:  T Shimizu; T Tajiri; H Yoshida; S Yokomuro; Y Mamada; N Taniai; Y Kawano; T Takahashi; Y Arima; T Aramaki; T Kumazaki
Journal:  Surg Endosc       Date:  2003-10       Impact factor: 4.584

9.  Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer.

Authors:  T Kanematsu; K Takenaka; T Matsumata; T Furuta; K Sugimachi; K Inokuchi
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

10.  Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver.

Authors:  Marco Vivarelli; Alfredo Guglielmi; Andrea Ruzzenente; Alessandro Cucchetti; Roberto Bellusci; Claudio Cordiano; Antonino Cavallari
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

View more
  4 in total

Review 1.  Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size.

Authors:  Yuesi Zhong; Meihai Deng; Ruiyun Xu
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

2.  Ramification of Glisson's sheath peripheral branches and clinical implications in the era of local ablation therapy.

Authors:  Jung Hun Lee; Guang Yu Jin; Zhe Wu Jin; Hee Chul Yu; Baik Hwan Cho
Journal:  Surg Radiol Anat       Date:  2010-03-04       Impact factor: 1.246

3.  Clinical analysis of anatomical resection for the treatment of hepatocellular carcinoma based on the stratification of liver function.

Authors:  Yusuke Yamamoto; Hisashi Ikoma; Ryo Morimura; Hirotaka Konishi; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Yoshiaki Kuriu; Takeshi Kubota; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Chouhei Sakakura; Toshiya Ochiai; Eigo Otsuji
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

Review 4.  Oncological outcomes of anatomic versus non-anatomic resections for small hepatocellular carcinoma: systematic review and meta-analysis of propensity-score matched studies.

Authors:  Xiao-Ming Dai; Zhi-Qiang Xiang; Qian Wang; Hua-Jian Li; Zhu Zhu
Journal:  World J Surg Oncol       Date:  2022-09-19       Impact factor: 3.253

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.